Aiach M - Search Results

1

Pharmacokinetic study of the low-molecular-weight heparin fraxiparin in patients with nephrotic syndrome.

Alhenc-Gelas M, Rossert J, Jacquot C, Aiach M. Alhenc-Gelas M, et al. Among authors: aiach m. Nephron. 1995;71(2):149-52. doi: 10.1159/000188703. Nephron. 1995. PMID: 8569945

2

Comparison of biological activities of two low molecular weight heparins in 10 healthy volunteers.

Azizi M, Veyssier-Belot C, Alhenc-Gelas M, Chatellier G, Billaud-Mesguish E, Fiessinger JN, Aiach M. Azizi M, et al. Among authors: aiach m. Br J Clin Pharmacol. 1995 Dec;40(6):577-84. Br J Clin Pharmacol. 1995. PMID: 8703665 Free PMC article. Clinical Trial.

3

[Treatment of venous thrombosis with low molecular weight heparin and fluindione].

Fiessinger JN, Paul JF, Alhenc-Gelas M, Veyssier C, Martin JB, Aiach M. Fiessinger JN, et al. Among authors: aiach m. Presse Med. 1992 Jan 18;21(2):65-8. Presse Med. 1992. PMID: 1311080 Clinical Trial. French.

4

Significance of high levels of heparin cofactor II in the plasma and urine of adult patients with nephrotic syndrome.

Toulon P, Gandrille S, Remy P, Chadeuf G, Jouvin MH, Aiach M. Toulon P, et al. Among authors: aiach m. Nephron. 1992;60(2):176-80. doi: 10.1159/000186735. Nephron. 1992. PMID: 1553002

5

An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.

Aiach M, François D, Priollet P, Capron L, Roncato M, Alhenc-Gelas M, Fiessinger JN. Aiach M, et al. Br J Haematol. 1987 Aug;66(4):515-22. doi: 10.1111/j.1365-2141.1987.tb01337.x. Br J Haematol. 1987. PMID: 3663508

6

Protein C infusion in a patient with inherited protein C deficiency caused by two missense mutations: Arg 178 to Gln and Arg-1 to His.

Alhenc-Gelas M, Emmerich J, Gandrille S, Aubry ML, Benaily N, Fiessinger JN, Aiach M. Alhenc-Gelas M, et al. Among authors: aiach m. Blood Coagul Fibrinolysis. 1995 Feb;6(1):35-41. doi: 10.1097/00001721-199502000-00006. Blood Coagul Fibrinolysis. 1995. PMID: 7795152 Review.

7

Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group.

Alhenc-Gelas M, Jestin-Le Guernic C, Vitoux JF, Kher A, Aiach M, Fiessinger JN. Alhenc-Gelas M, et al. Among authors: aiach m. Thromb Haemost. 1994 Jun;71(6):698-702. Thromb Haemost. 1994. PMID: 7974334 Clinical Trial.

8

[Changes in levels of blood coagulation inhibitors in cirrhosis. Prospective study in 33 patients].

Dumontier I, Alhenc-Gelas M, Chatellier G, Brenet P, Aiach M, Petite JP. Dumontier I, et al. Among authors: aiach m. Gastroenterol Clin Biol. 1992;16(2):120-5. Gastroenterol Clin Biol. 1992. PMID: 1314744 French.

9

Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency.

Vidaud D, Emmerich J, Alhenc-Gelas M, Yvart J, Fiessinger JN, Aiach M. Vidaud D, et al. Among authors: aiach m. J Clin Invest. 1992 May;89(5):1537-43. doi: 10.1172/JCI115746. J Clin Invest. 1992. PMID: 1569192 Free PMC article.

10

Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.

Toulon P, Jacquot C, Capron L, Frydman MO, Vignon D, Aiach M. Toulon P, et al. Among authors: aiach m. Thromb Haemost. 1987 Jun 3;57(3):263-8. Thromb Haemost. 1987. PMID: 3660328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters